We should have real oversight hearings to better understand the needs and to discover that there are gaps.
Greg Walden
The Public Record
Greg Walden is a former U.S. Representative from Oregon, serving in the House from 1999 to 2021. A member of the Republican Party, he represented Oregon's 2nd congressional district. During his tenure, Walden was known for his work on issues related to healthcare, telecommunications, and energy policy. He played a significant role in the passage of the 21st Century Cures Act, which aimed to accelerate medical product development and bring new innovations to patients more quickly.
It is critical we work toward ensuring that all diabetics have access to insulin.
But at the end of the day, we have to put the patient, the consumer, first in everything that we do.
I want to thank you for your work and look forward to your continued commitment to safety as confirmed Chair.
Cutting industry completely out of the process would benefit no one and would just increase the risk of keeping dangerous products potentially in the market longer.
CPSC protects consumers from unreasonable risks, and we know there are a lot of them out there.
It's imperative that the CPSC's process actually works to protect consumers and not lead to expensive and unneeded litigation.
Hopefully, your recent third vote of confidence by the Senate Commerce Committee will be the charm and your confirmation will move swiftly through the United States Senate.
We did that in a bipartisan way. We had some good, vigorous negotiations and that became law, the President signed it.
In my district I heard about it again when I did a series of town halls a week ago. Farmers and ranchers are pretty concerned, but appreciative of where you are taking that rule.
I appreciate your commitment, Mr. Administrator, this administration and its budget to three goals to the Agency's core mission, cooperative federalism, and rule of law and process.
It is my great honor and privilege to yield 2 minutes to the gentleman from Louisiana (Mr. Scalise), the Republican whip of the House, and an incredibly important member of our committee.
I thank the gentleman from South Carolina for his comments. Mr. Speaker, I would just point out Gallup just announced in a survey, 65 million Americans, 20 percent, put off treatment this last year and borrowed $88 billion to cover their…
I realize that today's hearing is more about the politics of climate change than rolling up our sleeves and getting to work on domestic solutions.
As you and I have discussed, Republicans are ready and willing to work with you on policies to continue America's leadership role in developing innovative technologies to produce energy with little or no emissions.
I know when Governor Inslee was in the House, we went toe to toe, and you opposed most of my efforts to get our forests back in balance and to reduce the threat of wildfires.
I look forward to hearing today about how we can encourage progress in the DADSS program as well as any other vehicle technology that can help eradicate drunk driving and save thousands of lives.
Nearly 11,000 Americans lose their lives on our roadways each year because of the reckless decision to get behind the wheel after having consumed alcohol.
The fact is, impaired driving, whether it be alcohol-impaired or drug-impaired, is a serious public risk that continues to tragically cut so many lives short.
I think we all agree that all working Americans, whether unionized or not, should not have to fear injury or illness every time they go to work.
We may disagree, Mr. Chairman, on the ways to solve various problems. We may disagree on the scope of certain problems. We may even disagree on the costs of the problem. But I know we all agree that all working Americans, whether unionized…
This bipartisan law has lowered the costs of important medications and devices, sped up how medical innovations come to fruition, and is a win for our healthcare workforce.
Thank you, Madam Chair, for hosting today's hearing--the first regarding the issue of drug pricing under the new majority.
Last Congress, as chairman of this committee, it was a priority of mine to make sure that patients could get streamlined access to more affordable prescription drugs.
I commend the President for taking such a monumental effort and hope to do what I can to support his plan.





